In summary, the combined findings from machine learning and single-cell analysis endorse LST1 as a pivotal candidate gene for comorbidity diagnosis, suggesting its potential key role in the progression of T2DM-ccRCC comorbidity through the regulation of macrophage-mediated efferocytosis and immune signaling. The gene discussed is LST1; the disease is type 2 diabetes mellitus.